SARS-CoV-2 (COVID-19) vaccine, mRNA-1273
RxNorm 2470232

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2470232 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: SARS-CoV-2 (COVID-19) vaccine, mRNA-1273.

The following semantic concepts and normalized strings are associated with this clinical entity:

PIN
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273
AUI:12525222
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PINPrescribable

Precise Ingredient (PIN):
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273
(Atom ID: 12525222)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2470232
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12525222
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PIN
Precise Ingredient (A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.)
Source Code
2470232
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

COVID-19 Vaccines


COVID-19 (coronavirus disease 2019) is an illness caused by a virus. This virus is a new coronavirus that has spread throughout the world. In the United States, there are several authorized and recommended vaccines to prevent COVID-19. These vaccines are being used under Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). These FDA decisions mean that the vaccines met the FDA's scientific standards for safety, effectiveness, and manufacturing quality needed to support EUA.

This page includes details about the vaccines and the vaccination program, including where you can find a vaccine. You can also find information about other COVID-19 vaccines that are still in progress. This includes details on how to volunteer for a vaccine clinical trial.

Centers for Disease Control and Prevention


[Learn More]


* Please review the disclaimer below.